Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer
- 1 August 1991
- journal article
- slide presentation
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 42 (2), 146-150
- https://doi.org/10.1016/0090-8258(91)90335-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.Journal of Clinical Oncology, 1987
- Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancerGynecologic Oncology, 1987
- Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1986
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- Surgery for common epithelial tumors of the ovaryCancer, 1981
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952